Researchers from Hospital Clínic and IDIBAPS lead an international study in which they have developed a genomic test to predict the response to chemotherapy in breast cancer. Hospital Clínic of Barcelona will be the first hospital in the world to implement this third generation test. This test is based on the data produced by the second-generation test PAM50, and for which Hospital Clínic is one of the reference centers. The article, published today in the journal Clinical Cancer Research, has been coordinated by Dr. Aleix Prat, Head of the Clinical Oncology Department at Hospital Clínic, the Translational genomics and targeted therapeutics in solid tumors research team at IDIBAPS and the Translational Genomics group of the Vall d’Hebron Institute of Oncology (VHIO). The study has involved several hospitals in Spain within the GEICAM breast cancer co-operative group, researchers from the University of North Carolina (USA), the Royal Marsden Foundation Trust in London, the University of Otago (New Zealand) and The University of Edinburgh (Scotland).
Physicians from Hospital Clinic, IDIBAPS and CAPSBE, awarded with the CoMB Professional Excellence Award 2016
Yesterday the Professional Excellence Prizes 2016 were awarded by the Col·legi de Metges de Barcelona (CoMB) to physicians in recognition to their career. In the present edition, six professionals working at Hospital Clínic, IDIBAPS and CAPSBE have been awarded.
Last Wednesday, November 23, was held in the Auditorium La Pedrera the 5th ceremony of delivery of the Fundació Catalunya-La Pedrera “Talents” Program grants, in which Hospital Clínic participates for the first time with the granting of two Scholarships. The event was chaired by the Health Minister of the Generalitat de Catalunya, Antoni Comín, who was accompanied by Ms. Marta Lacambra, CEO of the Catalunya-La Pedrera Foundation; Dr. Jordi Ara, ICS North Metropolitan Area Manager; And Dr. Josep Mª Campistol, CEO of the Hospital Clínic, who was also chosen godfather of this year’s promotion.
Gastroenterology has published a clinical trial promoted and coordinated by Hospital Clínic – IDIBAPS where it is shown that the addition of simvastatin to standard therapy in patients with cirrhosis can lengthen their survival. The article is signed by, among others, Dr. Jaume Bosch, hepatologist at Clínic and head of the research team Liver hemodynamics and portal hypertension of IDIBAPS; Dr. Juan Carlos García-Pagán and Juan González-Abraldes, from the same research group, and Dr. Fernando Torres, director of the IDIBAPS medical statistics platform. Read the rest of this entry »
Last Friday, November 18th, the celebration of the 20th anniversary of IDIBAPS was held. About 300 people gathered in the inner courtyard Beatriu de Pinós to listen to the speeches of Ramon Gomis, director of IDIBAPS, Francesc Subirada, general director of Research, Josep M. Campistol, general director of Hospital Clínic, Jaume Reventós, responsible of the Operations and Institutional Relations Department of the General Directorate of Research and Innovation of the Department of Health and Elías Campo, research director of Hospital Clínic and director of the Clinic Foundation for Biomedical Research.
On Wednesday 16 November the European Association for the Study of Diabetes (EASD) organized a round table in the European Parliament to discuss about the future of research on the disease in the European Union. The event was part of World Diabetes Day, celebrated on November 14th, and was hosted by the Catalan Member of the European Parliament Ernest Maragall. At the event attended Anna Novials, team leader of Pathogenesis and prevention of diabetes IDIBAPS and member of the EASD-EU committee, which works to positively influence the decisions of Parliament European funding on R & D in diabetes in Europe.